Dermatological Models: A Sound Basis for Early Decision-Making
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2-14.pdf
Continue Reading →
Current Edition
Current Edition
CDMO Subsection
Insights into the latest developments in CDMO services and manufacturing.
Continue readingInjectables Subsection
Expert perspectives on the evolving needs of injectable therapies and packaging.
Continue readingNasal & Pulmonary Subsection
Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability
Continue reading
Clinical Research v3i2
Adaptive Designs: A Method for the Future of Cancer Research
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2-13.pdf
Continue Reading →
Clinical Research v3i2
Implementing the Voluntary Harmonization Procedure for Accelerated Clinical Trial Approval
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2-12.pdf
Continue Reading →
Clinical Research v3i2
ePRO Technology Enables Reliable, Real-Time Suicidality Monitoring in Clinical Trials
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2-11.pdf
Continue Reading →
Clinical Research v3i2
Flexible Phase I Study Designs: Expediting Early Clinical Drug Development
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2-10.pdf
Continue Reading →
Drug Discovery, Development & Delivery v3i2
Promotion of aggregation via agitation as a Means of assessing the stability of antibody Molecules
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2-9.pdf
Continue Reading →
Drug Discovery, Development & Delivery v3i2
Fighting rare Diseases
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2-8.pdf
Continue Reading →
Drug Discovery, Development & Delivery v3i2
RGCC: A Leading Company in Analysis of CSCs as Progenitors of All Cancer Relapses
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2-7.pdf
Continue Reading →
Drug Discovery, Development & Delivery v3i2
Improving the human relevance of Preclinical trials
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2-6.pdf
Continue Reading →
Drug Discovery, Development & Delivery v3i2
A highly regulated environment for biomarker and biopharmaceutical testing
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-2-5.pdf
Continue Reading →
